focus -WSS

focus

author：focus 2025-09-03 03:33:03 - browse：3

Photo illustration of a checkbook wrapped with lock and chain – hospital and investment coverage from STAT — Alex Hogan/STAT

Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in an era of flattened margins and exceedingly uncertain returns, many health systems are quietly pulling back.

NewYork-Presbyterian’s venture firm, once managing roughly $40 million in assets, was essentially dissolved, two former employees said, with leaders punting it from the system’s strategy division to innovation, then from innovation to the investment office — a spokesperson described it as being “integrated” into the broader strategy. PitchBook data show no investments after 2020.

Advocate Health Enterprises, meanwhile, the venture firm of a 67-hospital system based in Charlotte, N.C., has lost at least six employees within the past year, including its president, from a staff that once included about a dozen people.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Lecanemab for Alzheimer's is coming. Is the health system ready?

explore

hotspot

WSS

Psilocybin's anti

Feds fine Medicare Advantage plans for overcharging members

Appeals court upholds limits to abortion pill

N.Y. state detects polio case, first in the U.S. since 2013

AstraZeneca bets AAV gene therapy will still deliver the goods

What do new weight loss drugs mean for bariatric surgery?

leisure time

focus

knowledge

Jerome Adams on the need for new antivirals for Covid

As pharma fights Medicare drug negotiation, hospitals, docs silent

Cancer drug shortages should be causing more outrage

Medicare explains how it will choose drugs for negotiation

Medical leaders decry Supreme Court decision on affirmative action

Neuroscience startup Neumora files for IPO

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Leqembi, other new Alzheimer’s drugs require better biomarkers

Virginia high school admissions case could be legal follow

Appeals court upholds limits to abortion pill

knowledge

New research casts further doubt on a common procedure used with IVF

Retired US general questions alleged Putin, Prigozhin meeting

NIH fellows want a pay raise. Will that mean less money for grants?

AstraZeneca challenges Medicare drug negotiation program

Radiation, mainstay of cancer treatment, begins a fade

How a symptom of dementia informs our understanding of creativity

explore

hotspot

focus

Wikipedia